Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.705 AUD | -0.70% | -0.70% | -21.67% |
Sales 2022 | 1.54M 1.01M 1.37M | Sales 2023 | 301K 197K 269K | Capitalization | 17.13M 11.19M 15.29M |
---|---|---|---|---|---|
Net income 2022 | -11M -7.19M -9.81M | Net income 2023 | -5M -3.27M -4.46M | EV / Sales 2022 | 4.57 x |
Net cash position 2022 | 2.25M 1.47M 2M | Net Debt 2023 | 292K 191K 260K | EV / Sales 2023 | 57.9 x |
P/E ratio 2022 |
-0.65
x | P/E ratio 2023 |
-2.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 51.29% |
Latest transcript on Zelira Therapeutics Limited
1 day | -0.70% | ||
1 week | -0.70% | ||
Current month | +0.71% | ||
1 month | -2.08% | ||
3 months | -18.97% | ||
6 months | -23.78% | ||
Current year | -21.67% |
Managers | Title | Age | Since |
---|---|---|---|
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Rahul Ganesan
DFI | Director of Finance/CFO | - | - |
Greg Blake
BRD | Director/Board Member | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Osagie Imasogie
CHM | Chairman | 62 | 19-11-27 |
Timothy Slate
BRD | Director/Board Member | - | 16-10-19 |
Oludare Odumosu
CEO | Chief Executive Officer | - | 19-11-27 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.705 | -0.70% | 269 |
24-04-24 | 0.71 | +1.43% | 1,279 |
24-04-23 | 0.7 | +1.45% | 174 |
24-04-22 | 0.69 | -2.82% | 490 |
24-04-19 | 0.71 | -1.39% | 3,894 |
Delayed Quote Australian S.E., April 26, 2024 at 01:44 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.67% | 5.22M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- ZLD Stock